Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Patriarch Partners is a New York-based private investment firm, family office, and holding company founded in 2000 by Lynn Tilton. The firm focuses on acquiring, restructuring, and revitalizing undervalued or distressed companies across a wide range of industries rather than operating as a life sciences, biotech, pharma, or healthcare company. Patriarch states that it has invested in or restructured more than 240 companies and has operated across 14 industry sectors through affiliated investment funds and portfolio companies. Its core business is turnaround investing, operational improvement, and long-term value creation, supported by in-house strategic, financial, legal, technology, and supply-chain capabilities. While some sources list life sciences and healthcare among sectors it may invest in, Patriarch itself is not a drug developer, therapeutic platform company, or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Patriarch Partners.